Cite
HARVARD Citation
Qiu, H. et al. (2018). Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor growth in cervical cancer and synergizes with Paclitaxel. Cell cycle. 17 (10), pp. 1235-1244. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Qiu, H. et al. (2018). Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor growth in cervical cancer and synergizes with Paclitaxel. Cell cycle. 17 (10), pp. 1235-1244. [Online].